Decoy Therapeutics, Inc. (DCOY)
3.03
-0.03
(-0.98%)
USD |
NASDAQ |
Sep 02, 16:00
3.03
0.00 (0.00%)
After-Hours: 18:10
Decoy Therapeutics Cash and Short Term Investments (Quarterly) : 8.289M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 8.289M |
| March 31, 2026 | 7.821M |
| December 31, 2025 | 10.71M |
| September 30, 2025 | 4.810M |
| June 30, 2025 | 0.7949M |
| March 31, 2025 | 1.798M |
| December 31, 2024 | 2.434M |
| September 30, 2024 | 3.284M |
| June 30, 2024 | 3.273M |
| March 31, 2024 | 4.373M |
| December 31, 2023 | 5.900M |
| September 30, 2023 | 7.581M |
| June 30, 2023 | 11.54M |
| March 31, 2023 | 9.274M |
| December 31, 2022 | 12.11M |
| September 30, 2022 | 16.82M |
| June 30, 2022 | 22.65M |
| March 31, 2022 | |
| December 31, 2021 | 29.21M |
| September 30, 2021 | 31.90M |
| June 30, 2021 | 33.08M |
| March 31, 2021 | 36.61M |
| December 31, 2020 | 11.12M |
| September 30, 2020 | 9.558M |
| Date | Value |
|---|---|
| June 30, 2020 | 7.223M |
| March 31, 2020 | 9.647M |
| December 31, 2019 | 3.739M |
| September 30, 2019 | 4.000M |
| June 30, 2019 | 6.514M |
| March 31, 2019 | 7.298M |
| December 31, 2018 | 6.132M |
| September 30, 2018 | 12.96M |
| June 30, 2018 | 15.76M |
| March 31, 2018 | 23.95M |
| December 31, 2017 | 33.32M |
| September 30, 2017 | 38.93M |
| June 30, 2017 | 47.12M |
| March 31, 2017 | 52.81M |
| December 31, 2016 | 61.08M |
| September 30, 2016 | 67.33M |
| June 30, 2016 | 74.85M |
| March 31, 2016 | 84.38M |
| December 31, 2015 | 91.34M |
| September 30, 2015 | 99.16M |
| June 30, 2015 | 106.01M |
| March 31, 2015 | 110.52M |
| December 31, 2014 | 33.85M |
| September 30, 2014 | 36.29M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Palatin Technologies, Inc. | 10.16M |
| Unicycive Therapeutics, Inc. | 61.42M |
| Nuvectis Pharma, Inc. | 22.16M |
| ACADIA Pharmaceuticals, Inc. | 956.47M |
| Alnylam Pharmaceuticals, Inc. | 3.308B |